The Law Offices of Frank R. Cruz announces an investigation of Merck & Co (“Merck” or the “Company”) (NYSE: MRK) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON MERCK & CO (MRK), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck’s Chinese distributer. The Company announced that its shipments of Gardasil to China may fall below contracted levels for 2024.

On this news, Merck’s stock price fell $12.53, or 9.8%, to close at $115.25 per share on July 30, 2024, thereby injuring investors.

Then, on February 4, 2025, Merck disclosed that it would entirely cease shipments of Gardasil to China “through at least midyear” to facilitate a “rapid reduction of inventory,” citing a continued over-inflation of channel inventories as demand in China had “not recovered to the level [the Company] had expected.” Merck also announced that it would no longer achieve its long-forecasted $11 billion in sales of Gardasil by 2030.

On this news, Merck’s stock price fell $9.05, or 9.1%, to close at $90.74 per share on February 4, 2025, thereby injuring investors further.

Contact Us To Participate or Learn More:

If you purchased Merck securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250219548651/en/